Andrikopoulos George K, Tzeis Stylianos E, Pipilis Athanasios G, Richter Dimitri J, Kappos Konstantinos G, Stefanadis Christodoulos I, Toutouzas Pavlos K, Chimonas Elias T
First Cardiac Department, Evangelismos Hospital, Athens, Greece.
Int J Cardiol. 2006 Apr 14;108(3):320-5. doi: 10.1016/j.ijcard.2005.05.016. Epub 2005 Jun 15.
Female patients with acute myocardial infarction (MI) exhibit higher unadjusted in-hospital mortality rates compared to male patients. However, contradictory evidence exists on whether this survival disadvantage disappears after adjustment for age and other prognostic factors. This study, based on a countrywide survey of consecutive unselected patients with acute MI, examined whether female gender is an independent predictor of poor short-term outcome and less intensive in-hospital treatment.
Data on a total of 7433 patients were analyzed.
The mean age was 64+/-13 years and the proportion of females in this population was 23%. Univariate and multivariate predictors of in-hospital mortality in female patients were estimated. Unadjusted in-hospital mortality rates of women were significantly higher compared to men (17.7 vs. 8.6, p<0.001). In multivariate analysis, female gender was an independent predictor of in-hospital mortality in the total population [relative risk (RR)=1.29, 95% confidence interval (CI)=1.02-1.64, p=0.036]. The RR of women for in-hospital death was exaggerated among younger patients, aged <55 years (RR=3.84, 95% CI=1.07-13.74, p=0.039). Female gender was also independently and inversely associated with administration of thrombolytic treatment (RR=0.724, 95% CI=0.630-0.831, p=<0.001).
Although female gender is an independent predictor of higher post-MI in-hospital mortality with a pronounced effect among younger patients, women are less likely to receive thrombolysis than men. Based on the results from this countrywide study, we should consider women, especially of younger age, as patients at particular high risk, who contrary to common practice, deserve more intensive and aggressive in-hospital treatment.
与男性患者相比,急性心肌梗死(MI)女性患者未经调整的院内死亡率更高。然而,对于在调整年龄和其他预后因素后这种生存劣势是否消失,存在相互矛盾的证据。本研究基于一项对全国范围内连续入选的急性MI患者的调查,探讨女性性别是否是短期预后不良和院内治疗强度较低的独立预测因素。
分析了总共7433例患者的数据。
平均年龄为64±13岁,该人群中女性比例为23%。对女性患者院内死亡的单因素和多因素预测因素进行了评估。女性未经调整的院内死亡率显著高于男性(17.7%对8.6%,p<0.001)。在多因素分析中,女性性别是总体人群院内死亡的独立预测因素[相对风险(RR)=1.29,95%置信区间(CI)=1.02 - 1.64,p = 0.036]。在年龄<55岁的年轻患者中,女性院内死亡的RR被夸大(RR = 3.84,95% CI = 1.07 - 13.74,p = 0.039)。女性性别还与溶栓治疗的使用独立且呈负相关(RR = 0.724,95% CI = 0.630 - 0.831,p<0.001)。
尽管女性性别是MI后院内死亡率较高的独立预测因素,且在年轻患者中影响显著,但女性接受溶栓治疗的可能性低于男性。基于这项全国性研究的结果,我们应将女性,尤其是年轻女性,视为特别高危的患者,与常规做法相反,她们应在院内接受更积极强化的治疗。